IS5117A - Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)-2-(6,7-dimethoxynapht-2-yl)ethane for preparing medicines for the treatment of cerebral and neuronal disorders - Google Patents
Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)-2-(6,7-dimethoxynapht-2-yl)ethane for preparing medicines for the treatment of cerebral and neuronal disordersInfo
- Publication number
- IS5117A IS5117A IS5117A IS5117A IS5117A IS 5117 A IS5117 A IS 5117A IS 5117 A IS5117 A IS 5117A IS 5117 A IS5117 A IS 5117A IS 5117 A IS5117 A IS 5117A
- Authority
- IS
- Iceland
- Prior art keywords
- dimethoxynapht
- tetrahydropyrid
- trifluoromethylphenyl
- cerebral
- ethane
- Prior art date
Links
- -1 4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyrid-1-yl Chemical group 0.000 title 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR1997/000202 WO1998033502A1 (fr) | 1997-02-03 | 1997-02-03 | Utilisation du 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane pour la preparation de medicaments destines aux traitements de troubles cerebraux et neuronaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5117A true IS5117A (is) | 1999-07-15 |
Family
ID=9502506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5117A IS5117A (is) | 1997-02-03 | 1999-07-15 | Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)-2-(6,7-dimethoxynapht-2-yl)ethane for preparing medicines for the treatment of cerebral and neuronal disorders |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0954311A1 (cs) |
| JP (1) | JP2001511141A (cs) |
| AU (1) | AU1607397A (cs) |
| CA (1) | CA2279326A1 (cs) |
| CZ (1) | CZ275399A3 (cs) |
| EE (1) | EE9900332A (cs) |
| HU (1) | HUP0000767A3 (cs) |
| IL (1) | IL130994A0 (cs) |
| IS (1) | IS5117A (cs) |
| TR (1) | TR199901722T2 (cs) |
| WO (1) | WO1998033502A1 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6272180B1 (en) * | 1997-11-21 | 2001-08-07 | Sharp Laboratories Of America, Inc. | Compression and decompression of reference frames in a video decoder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| US5618822A (en) * | 1990-05-23 | 1997-04-08 | Sanofi | N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
-
1997
- 1997-02-03 HU HU0000767A patent/HUP0000767A3/hu unknown
- 1997-02-03 EP EP97902426A patent/EP0954311A1/fr not_active Withdrawn
- 1997-02-03 TR TR1999/01722T patent/TR199901722T2/xx unknown
- 1997-02-03 CZ CZ992753A patent/CZ275399A3/cs unknown
- 1997-02-03 JP JP53257498A patent/JP2001511141A/ja active Pending
- 1997-02-03 EE EEP199900332A patent/EE9900332A/xx unknown
- 1997-02-03 AU AU16073/97A patent/AU1607397A/en not_active Abandoned
- 1997-02-03 CA CA002279326A patent/CA2279326A1/fr not_active Abandoned
- 1997-02-03 WO PCT/FR1997/000202 patent/WO1998033502A1/fr not_active Ceased
- 1997-02-03 IL IL13099497A patent/IL130994A0/xx unknown
-
1999
- 1999-07-15 IS IS5117A patent/IS5117A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0954311A1 (fr) | 1999-11-10 |
| CZ275399A3 (cs) | 1999-12-15 |
| IL130994A0 (en) | 2001-01-28 |
| CA2279326A1 (fr) | 1998-08-06 |
| EE9900332A (et) | 2000-02-15 |
| AU1607397A (en) | 1998-08-25 |
| WO1998033502A1 (fr) | 1998-08-06 |
| TR199901722T2 (xx) | 2000-08-21 |
| HUP0000767A3 (en) | 2000-10-30 |
| JP2001511141A (ja) | 2001-08-07 |
| HUP0000767A2 (hu) | 2000-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200274A (et) | Pürrolidiinatseetamiidi derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete ravimiseks, ja farmatseutiline kompositsioon | |
| NO20004915L (no) | Transdermalt terapeutisk system som inneholder en D2-agonist og som tilveiebringes for behandling av Parkinsons sykdom og en fremgangsmÕte for dets fremstilling | |
| EE200200442A (et) | Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks | |
| NO20003288D0 (no) | Preparat for behandling av respiratoriske sykdommer og hudsykdommer, omfattende minst en leukotrienantagonist og minst ett antihistamin | |
| FI20000720A7 (fi) | Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi | |
| CY2013041I1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
| DK629989D0 (da) | Oralt, antiseptisk middel, dets fremstilling og anvendelse samt produkter, hvori det indgaar | |
| FI971566L (fi) | Kompakti lääkeannostelija sisäänhengitettävien lääkepartikkelien generoimiseksi | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| ES2159362T3 (es) | Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica. | |
| NZ502495A (en) | Use of a specific antagonist of 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of sleep apnoea syndrome | |
| HUP0204050A3 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
| NO306060B1 (no) | Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene | |
| SE9903995D0 (sv) | New combination | |
| EE200100553A (et) | Saredutandi ja selle farmatseutiliselt vastuvõetavate soolade kasutamine meeleoluhäirete, kohanemishäirete või segatüüpi ärev-depressiivsete häirete raviks või vältimiseks kasulike ravimite valmistamiseks | |
| IS5117A (is) | Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)-2-(6,7-dimethoxynapht-2-yl)ethane for preparing medicines for the treatment of cerebral and neuronal disorders | |
| NO973531D0 (no) | Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet | |
| BR0008703A (pt) | Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência | |
| FI950725A7 (fi) | Trisyklisen yhdisteen käyttö muistin ja tajunnan häiriöiden hoitoon tarkoitettujen lääkevalmisteiden valmistukseen | |
| NZ508325A (en) | Microemulsion preconcentrates for oral administration containing a piperidine substance P antagonist | |
| NO993728D0 (no) | Anvendelse av 1-[4-(3-trifluormeylfenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimetoksynaft-2yl)etan for fremstilling av medikamenter for behandling av cerebrale og nevronale forstyrrelser | |
| FI953622A7 (fi) | Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon | |
| BR9714486A (pt) | Utilização de 1-[4-(3-trifluorometilfenil)- 1,2,3,6-tetra-hidropirid-1-il]-2-(6,7-dimetoxinaft-2-il) etano | |
| ITTO971062A0 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
| ZA921101B (en) | Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders. |